TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
MANE

Veradermics, Incorporated

Healthcare · Biotechnology

116.60$ +0.7% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns Veradermics, Incorporated (MANE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 77.3% of the shares are freely tradable; institutional investors hold 88.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 88.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 77.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 14.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 42Mio.

Largest Shareholders

Institutions

Institutions MANE
Name Stake (%) Shares Change (%) Date
Suvretta Capital Management, LLC 9.98 4,168,970 +0.0 03/31/2026
SR ONE CAPITAL MANAGEMENT, LP 5.75 2,401,868 +0.0 06/30/2026
Deep Track Capital, LP 4.79 2,000,000 +300.0 06/30/2026
Citadel Advisors Llc 4.49 1,877,775 +2.9 06/30/2026
FMR Inc 4.29 1,792,909 +0.0 03/31/2026
Viking Global Investors LP 4.05 1,690,555 +0.0 03/31/2026
Siren, L.L.C. 3.60 1,505,374 +0.0 03/31/2026
Aberdeen Group PLC 2.62 1,096,642 +4.0 06/30/2026
D. E. Shaw & Co LP 2.43 1,013,643 +655.2 06/30/2026
JPMorgan Chase & Co 2.34 976,166 +0.0 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings MANE
Person Role Shares Value As of Type
Montanova Capital, Llc Director 612,033 71,363,048 $ Aug 20, 2026 indirect
Childs John W Director 194,117 22,634,042 $ Aug 12, 2026 indirect
Waldman Reid Alexander Chief Executive Officer 170,824 19,918,078 $ Aug 17, 2026 direct
Durso Timothy August Chief Technical Officer 78,142 9,111,357 $ Aug 17, 2026 direct
Hollander David Chief R&D Officer 9,650 1,125,190 $ Sep 1, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 1, 2026 Hollander David Chief R&D Officer Other 9,650 0.00 –
Aug 20, 2026 Montanova Capital, Llc Director Other 151,000 – –
Aug 20, 2026 Montanova Capital, Llc Director Other 149,000 – –
Aug 19, 2026 Montanova Capital, Llc Director Sell 59,399 107.25 6,370,543
Aug 19, 2026 Montanova Capital, Llc Director Sell 690,601 107.25 74,066,957
Aug 17, 2026 Durso Timothy August Chief Technical Officer Sell 161 111.28 17,916
Aug 17, 2026 Durso Timothy August Chief Technical Officer Sell 2,348 109.34 256,730
Aug 17, 2026 Durso Timothy August Chief Technical Officer Sell 16,767 108.38 1,817,207
Aug 17, 2026 Durso Timothy August Chief Technical Officer Sell 16,306 107.52 1,753,221
Aug 17, 2026 Durso Timothy August Chief Technical Officer Sell 7,918 106.71 844,930
Aug 17, 2026 Durso Timothy August Chief Technical Officer Other 3,452 12.19 42,080
Aug 17, 2026 Waldman Reid Alexander Chief Executive Officer Sell 249 111.28 27,709
Aug 17, 2026 Waldman Reid Alexander Chief Executive Officer Sell 3,000 109.38 328,140
Aug 17, 2026 Waldman Reid Alexander Chief Executive Officer Sell 27,490 108.45 2,981,291
Aug 17, 2026 Waldman Reid Alexander Chief Executive Officer Sell 25,234 107.53 2,713,412
Aug 17, 2026 Waldman Reid Alexander Chief Executive Officer Sell 11,527 106.72 1,230,161
Aug 17, 2026 Waldman Reid Alexander Chief Executive Officer Other 3,452 12.19 42,080
Aug 12, 2026 Childs John W Director Sell 5,000 108.24 541,200
Aug 12, 2026 Childs John W Director Sell 80,000 107.23 8,578,400
Aug 12, 2026 Childs John W Director Sell 15,000 106.14 1,592,100

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?